Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.460 +0.380 (+12.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

December 02, 2022

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.

Via Benzinga

Anavex Life Sciences (NASDAQ: AVXL) Says Phase 2b/3 for ANAVEX2-73 Met Primary and Secondary Endpoints Reducing Cognative Decline in Patients with Early Alzheimer’s

December 02, 2022

Anavex Life Sciences Corp. (NASDAQ: AVXL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and

Via Spotlight Growth

Anavex Catapults On Alzheimer's Results — But Math Question Clouds The Data ↗

December 02, 2022

A math error could have clouded the drug's actual benefits.

Via Investor's Business Daily

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,500 Today ↗

December 02, 2022

Via Benzinga

Earnings Preview: Anavex Life Sciences ↗

November 25, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 02, 2022

Via Benzinga

Gold Down 1%; Samsara Shares Spike Higher ↗

December 02, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 75 points on Friday.

Via Benzinga

Why Anavex Life Sciences Stock Is Surging Today ↗

December 02, 2022

The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.

Via The Motley Fool

Rigel Pharmaceuticals (RIGL) Stock Soars on FDA Approval News ↗

December 02, 2022

Rigel Pharmaceuticals (RIGL) stock is heading higher on Friday after getting approval from the FDA for its leukemia treatment.

Via InvestorPlace

Why Is Anavex Life Sciences (AVXL) Stock Up 30% Today? ↗

December 02, 2022

Anavex Life Sciences (AVXL) stock is rocketing higher on Friday following positive results from an Alzheimer’s clinical trial.

Via InvestorPlace

Smartsheet, Samsara, Anavex Life Sciences And Some Other Big Stocks Moving Higher On Friday ↗

December 02, 2022

U.S. stocks traded mostly lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs ↗

December 02, 2022

U.S. stocks traded lower this morning, with the Dow Jones falling more than 300 points on Friday following the release of jobs data for November.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 02, 2022

Via Benzinga

Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It' ↗

December 01, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Williams Companies, Inc. (NYSE: WMB) is "terrific." He recommended buying the stock.

Via Benzinga

Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

November 28, 2022

Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns.

Via Benzinga

Why Shares of Anavex Life Sciences Slumped 23.5% on Monday ↗

November 28, 2022

The company released its fourth-quarter and full-year numbers.

Via The Motley Fool

Dow Tumbles 450 Points; S&P 500 Falls 1.5% ↗

November 28, 2022

U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.

Via Benzinga

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 28, 2022

Via Benzinga

Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher ↗

November 28, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.

Via Benzinga

CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday ↗

November 28, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Earnings Scheduled For November 28, 2022 ↗

November 28, 2022

Companies Reporting Before The Bell • Pinduoduo (NASDAQ:PDD) is projected to report quarterly earnings at $0.65 per share on revenue of $4.31 billion.

Via Benzinga

This Stock Is Up 106% In 2022 And Analysts Love It, But Jim Cramer Says 'There's Too Much Political Risk' ↗

November 15, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is a "very early stage company that has a lot in the pipe. I tend to like these companies."

Via Benzinga

Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients

October 20, 2022

Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...

Via FinancialNewsMedia

10 Health Care Stocks Whale Activity In Today's Session ↗

July 14, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday ↗

July 19, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.

Via Benzinga

Anavex: Alzheimer's To Parkinson's Dementia ↗

April 15, 2022

Following a huge gain in 2021 (after a big gain in 2020), the shares have given back 27% year-to-date as investors ride out a quiet stretch awaiting trial results.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022 ↗

June 23, 2022

Upgrades

Via Benzinga

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL

April 05, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Anavex Life Sciences Corp. (NASDAQ:AVXL) Investor Alert: Investigation over Potential Wrongdoing ↗

March 21, 2022

San Diego, CA -- (SBWIRE) -- 03/21/2022 -- An investigation on behalf of investors in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) was announced over potential breaches of fiduciary duties by...

Via SBWire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

All News about Anavex Life Sciences Corp. - Common Stock

Starting at $3.75/week.

Subscribe Today